logo
Share SHARE
FONT-SIZE Plus   Neg

Bio-Reference Labs. Posts Lower Q1 Profit - Quick Facts

Bio-Reference Laboratories Inc.'s (BRLI) first-quarter net income decreased to $7.36 million or $0.26 per share from $7.99 million or $0.28 per share last year.

The company recorded quarterly revenues of $149.92 million, a 23% increase over $121.66 million reported in the prior-year quarter.

On average, 5 analysts polled by Thomson Reuters expected earnings per share of $0.21 on $143.13 million revenue for the quarter. Analysts' estimates typically exclude one-time items.

Marc Grodman, MD, CEO, commented: "The milder than normal weather conditions, particularly in the Northeast, have contributed to the strength of our Q1 results when compared to our prior year results. However, and more importantly, the overall success of all our business units has been the primary reason for our strong financial results."

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Red-hot Las Vegas beat other big cities to become the best and most budget-friendly summer travel destination this year, according to financial website WalletHub. WalletHub's Shares of Allergan plc rose in early trades Tuesday after billionaire investor Carl Icahn said he recently acquired a "large position" in the Botox maker and was very supportive of CEO Brent Saunders. Icahn did not disclose details of the stake he acquired in Allergan. Shares of Volkswagen AG declined around 3 percent in the morning trading, after the German automotive giant reported Tuesday lower profit and revenues in its first quarter, mainly reflecting weak passenger car volumes and negative currency impacts. Further, the company reiterated its outlook for fiscal 2016, expecting a decline in revenues.
comments powered by Disqus
Follow RTT